-
Mashup Score: 4Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs to Improve Statin Rates (NOTIFY-1 Project) - 1 year(s) ago
Background: Coronary artery calcium (CAC) can be identified on non-gated chest CTs, but this finding is not consistently incorporated into care. A deep learning algorithm enables opportunistic CAC sc
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 11Empagliflozin in Black Versus White Patients with Heart Failure: Analysis of EMPEROR-Pooled - 1 year(s) ago
Nitish K. DhingraNitish K. Dhingra Division of Cardiac Surgery, St. Michael’s Hospital, University of Toronto, Toronto, Canada , Stefan D. AnkerStefan D. Anker https://orcid.org/0000-0002-0805-8683 Department of Cardiology (CVK) and Berlin Institute of Health Center for Regenerative Therapies, German Centre for Cardiovascular Research Partner Site Berlin, Charité Universitätsmedizin, Berlin,…
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: The efficacy and safety of #empagliflozin was similar in Black and White patients with HF across the range of EF, with a suggestion of enhanced efficacy in Black patient... @JavedButler1 @FaiezZANNAD @lamcardio https://t.co/c7LMA1O9yL https://t.co/8wihsizMAK
-
-
Mashup Score: 0
Background: Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as a key pharmacotherapy in heart failure (HF) with both reduced and preserved ejection fraction. The benefit of other HF th
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#JustPublished #AHA22 #CIRCAHA22 : Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER #AHAJournals https://t.co/PTnF0zi5kO
-
-
Mashup Score: 1
Alexandra C. Murphy * Corresponding Author; email: E-mail Address: [email protected] https://orcid.org/0000-0002-4248-7537 Austin Health, Melbourne, Australia; The University of Melbourne, Melbourne, Australia; Olivia Newton John Cancer and Wellness Centre, Melbourne, Australia; Epworth Richmond, Melbourne, Australia; Bendigo Health, Bendigo, Australia; Curtin University, Perth, Australia …
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#JustPublished: #AHA22 #CIRCAHA22 SMARTphone-Based Cardiovascular Risk Reduction in BREAST Cancer Patients [SMART-BREAST]: A Randomized Controlled Trial #AHAJournals https://t.co/86Y0PnbYDI
-
-
Mashup Score: 9Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study - 1 year(s) ago
Background: Long term outcomes of antiplatelet monotherapy in patients who receive percutaneous coronary intervention (PCI) are unknown. The HOST-EXAM Extended study reports the post-trial follow-up
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: In the #HOST-EXAM Extended Study, clopidogrel monotherapy had lower risk of thrombotic and bleeding events compared w/ aspirin monotherapy among patients w/o clinical events for 12mo after DES https://t.co/aI4xjHdBaB https://t.co/2sPcy9279N
-
-
Mashup Score: 2
Background: The ISCHEMIA trial compared an initial invasive versus an initial conservative management strategy for patients with chronic coronary disease and moderate or severe ischemia, with no majo
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: From the #ISCHEMIA-EXTEND study - No difference in all-cause mortality between initial invasive vs conservative strategy but ⬇️ risk of CV mortality and ⬆️ risk of non-CV mortality w/ initial invasive strat... https://t.co/XwFS1KO02z https://t.co/SG2z4D3lzY
-
-
Mashup Score: 0
Background: Dual antiplatelet therapy (DAPT) with aspirin as a background therapy has become the standard care following percutaneous coronary intervention (PCI). However, some adverse non-cardiac ef
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: In this #RCT, indobufen + clopidogrel DAPT compared with aspirin + clopidogrel DAPT significantly reduced the risk of 1-year net clinical outcomes, mainly driven by a reduction in bleeding events without an ....https://t.co/ctk1fwhXt2 https://t.co/vFPS6gvpjN
-
-
Mashup Score: 0Dose-Blinded Myosin Inhibition in Patients with Obstructive HCM Referred for Septal Reduction Therapy: Outcomes Through 32-Weeks - 1 year(s) ago
Background: Septal reduction therapy (SRT) in patients with intractable symptoms from obstructive hypertrophic cardiomyopathy (oHCM) is associated with variable morbidity and mortality. The VALOR-HCM
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalReseach #simpub #AHA2022 #CIRCAHA22 In Valor-HCM, Myosin Inhibition with Mavacamten reduced the need for septal reduction therapy at 32 weeks with ↓LVOT gradients ↑quality of life, and positive cardiac remodeling @DesaiMilindY #AHAJournals https://t.co/Gw76ZnL18S https://t.co/cNZS4FXL8e
-
-
Mashup Score: 2Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Results of the ECMO-CS Randomized Clinical Trial - 1 year(s) ago
Background: Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly being used for circulatory support in cardiogenic shock patients, although the evidence supporting its use in t
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022: In this #RCT immediate implementation of VA-ECMO in patients with cardiogenic shock did not improve clinical outcomes compared with an early conservative strategy which allowed downstream use of... #CIRCAHA22 #AHAJournals https://t.co/03qVyC0Vgl https://t.co/WRNDsAZfpD
-
-
Mashup Score: 8
Background: Acetazolamide inhibits proximal tubular sodium reabsorption and improved decongestion in the Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR) trial. It remains un
Source: CirculationCategories: Cardiology News and Journals, Latest HeadlinesTweet-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: Acetazolamide added to loop diuretics ⬆️ likelihood of successful decongestion similarily in patients with HFrEF, HFmrEF and HFpEF. Data from the #ADVOR trial. @PieterMartensMD @WilfriedMullens #AHAJournals https://t.co/MkISN2H1vA https://t.co/qFjCKdRaF6
-
#OriginalResearch simpub #AHA2022 #CIRCAHA22: Notifying clinicians and statin-naïve patients of incidental #CAC identified on prior, non-gated chest CT via #AI DL algorithm increased statin rates to 51% (vs 7% in usual care). @ATSandhu https://t.co/Vm2pIJ9gpV https://t.co/Q3GJc2qXOJ